Efficacy of Spironolactone Compared with Doxycycline in Moderate Acne in Adult Females: Results of the Multicentre, Controlled, Randomized, Double-blind Prospective and Parallel Female Acne Spironolactone vs doxyCycline Efficacy (FASCE) Study.

Publication Year: 2024

DOI:
10.2340/actadv.v104.26002

PMCID:
PMC10910526

PMID:
38380975

Journal Information

Full Title: Acta Derm Venereol

Abbreviation: Acta Derm Venereol

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Sexually Transmitted Diseases

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
4/6
66.7% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"The authors have no conflicts of interest to declare."

Evidence found in paper:

"This study was supported by a grant from the French Ministry of Health (PHRC-16-0290)."

Evidence found in paper:

"Clinical Trial Identifier. NCT05486910. The study received ethics committee approval from CPP SUD OUEST and OUTRE MER on 3 October 2017 (Clinical Trial identifier NCT03334682 and EudraCT number: 2017-001392-22). The study complied with all local legal requirements for the conduct of clinical trials and conformed with Good Clinical Practice and the principles of the Declaration of Helsinki. The study received ethics committee approval from Comité de Protection des Personnes SUD OUEST and OUTRE MER on 3 October 2017 (Clinical Trial identifier NCT03334682 and EudraCT number: 2017-001392-22). The patients provided written informed consent to publication of their case details."

Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025